How to buy Novacyt shares

Learn how to easily invest in Novacyt shares.

Novacyt (NCYT) is a publicly traded medical devices business based in the UK which employs around 250 staff. Novacyt is listed on the London Stock Exchange (LSE) and traded in sterling. Its current price of 52.70p is 24.6% down on its price a month ago (69.90p).

How to buy shares in Novacyt

  1. Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
  2. Fund your account. Add money to your account via bank transfer, debit card or credit card.
  3. Search the platform by ticker symbol. NCYT in this case.
  4. Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
  5. Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy Novacyt shares

Best for 0% commission stocks
eToro Free Stocks logo
Finder Award
Go to site
Capital at risk. Fees apply.
Copy picks from top traders
4.3 ★★★★★
Commission-free trades
Fractional shares
Get dividend payments
Best for fractional shares
XTB logo
Go to site
Capital at risk. T&Cs apply.
Earn 5% on uninvested funds
4.4 ★★★★★
Commission-free trades
Fractional shares
5,400+ stocks/ETFs
Best for US shares
CMC Invest share dealing account logo
Finder Award
Go to site
Capital at risk. T&Cs apply.
Try Plus free for 3 months
4.4 ★★★★★
Commission-free trades
3,000+ stocks
Real-time live pricing

Fees calculator for buying Novacyt shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

1000
Platform Finder Score Account fee Min. initial deposit Trade cost Link
eToro Free Stocks logo
4.3 ★★★★★
£0 $100 £533.61
Go to siteCapital at risk
Freetrade logo
4.4 ★★★★★
£0 £1 £529.64
Go to siteCapital at risk
Trading212 logo
4.7 ★★★★★
£0 £1 £529.64
Go to siteCapital at risk
XTB logo
4.4 ★★★★★
£0 £0 £529.64
Go to siteCapital at risk
CMC Invest share dealing account logo
4.4 ★★★★★
£0 £0 £529.64
Go to siteCapital at risk
Hargreaves Lansdown Fund and Share Account logo
4.2 ★★★★★
£0 (0.45% for funds) £1 £541.59
Go to siteCapital at risk
InvestEngine logo
4.4 ★★★★★
0% - 0.25% £100 £529.64
Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Alternative ways to invest in Novacyt

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Novacyt), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

Novacyt is a major part of the London stock exchange, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy Novacyt stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View Novacyt's price performance, share price volatility, historical data and technicals.

Use our graph to track the performance of NCYT stock over time.

Historical closes compared with the last close of 52.70

1 week (2024-10-31)-5.72%
1 month (2024-10-07)-24.61%
3 months (2024-08-07)5.61%
6 months (2024-05-07)-23.62%
1 year (2023-11-07)18.43%
2 years (2022-11-07)-30.42%
3 years (2021-11-07)-79.89%
5 years (2019-11-07)710.77%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Promoted
eToro Free Stocks
Invest in Novacyt shares
Finder Award
  • Start investing from $100
  • Pay no stamp duty on UK shares
  • Commission-free trading. Other fees may apply.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Is Novacyt under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Novacyt P/E ratio, PEG ratio and EBITDA.

Novacyt's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Novacyt's shares trade at around 0x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the United Kingdom stock market as of 09 November, 2023 (10). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Novacyt's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give None. Higher PEG ratios such as this can be interpreted as meaning the shares offer worse value given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Novacyt's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


More guides on Finder

Go to site